Informed consent in cancer clinical drug trials in China: a narrative literature review of the past 20 years.

ABSTRACT:

Background

Although the number of cancer clinical drug trials is increasing rapidly in China, issues concerning informed consent in this research context are understudied. By performing a narrative literature review, we aim to describe the current situation and identify the most salient challenges affecting informed consent in cancer clinical drug trials among adult patients in China since 2000.

Methods

We searched Web of Science (WOS), PubMed, Scopus, EMBASE, the Cochrane Library databases, China National Knowledge Infrastructure (CNKI), China Biomedical Literature Database on Disc (CBMdisc), Chinese Scientific Journals Fulltext Database (CQVIP), and WANFANG Data to identify relevant publications since 2000. Data were extracted by three reviewers on six items pertaining to

SUBMITTER: Liu X 

PROVIDER: S-EPMC10327323 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature